Interested parties can access a live audio web cast of the presentation at http://www.abiomed.com. A replay of the presentation will be available at the same location.

Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB’-EE-O-MED") is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. ABIOMED, which currently sells the BVS® 5000 Biventricular Support System and the AB5000™ Circulatory Support System, is the market leader in devices for the temporary support of patients with failing but potentially recoverable hearts. In September 2004, ABIOMED applied for initial FDA market approval for the AbioCor Implantable Replacement Heart to treat a defined subset of irreversible end-stage heart failure patients under a Humanitarian Device Exemption.

###

Media Contact:
Andrea tenBroek
Communications Specialist
(978) 646-1815
mediarelations@abiomed.com

Investor Relations Contact:
Jane Petrino
Noonan/ Russo
(212) 845-4274
jane.petrino@eurorscg.com